Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-24

Clinical Trial Update: A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion [Phase 3]

View source ↗

Summary

Phase 3 trial investigating safety and tolerability of high-dose oxycodone hydrochloride infusion; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone hydrochloride (Oxycodone hydrochloride)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Severe Caner Pain | Phase 3 | Status: TERMINATED